Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2015 1
2018 4
2019 2
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review.
Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Yamamura D, Mertz D; McMaster Infectious Diseases Fellow Research Group. Komorowski AS, et al. Among authors: fuller c. Clin Microbiol Infect. 2022 May;28(5):640-648. doi: 10.1016/j.cmi.2021.11.003. Epub 2021 Nov 8. Clin Microbiol Infect. 2022. PMID: 34763055 Free article. Review.
Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9.
Prykhozhij SV, Fuller C, Steele SL, Veinotte CJ, Razaghi B, Robitaille JM, McMaster CR, Shlien A, Malkin D, Berman JN. Prykhozhij SV, et al. Among authors: fuller c. Nucleic Acids Res. 2018 Sep 28;46(17):e102. doi: 10.1093/nar/gky512. Nucleic Acids Res. 2018. PMID: 29905858 Free PMC article.
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?
Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Leto DL, Yamamura D, Mertz D; McMaster Infectious Diseases Fellow Research Group. Komorowski AS, et al. Among authors: fuller c. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0162721. doi: 10.1128/AAC.01627-21. Epub 2021 Oct 18. Antimicrob Agents Chemother. 2022. PMID: 34662190 Free PMC article.
Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9.
Prykhozhij SV, Fuller C, Steele SL, Veinotte CJ, Razaghi B, Robitaille JM, McMaster CR, Shlien A, Malkin D, Berman JN. Prykhozhij SV, et al. Among authors: fuller c. Nucleic Acids Res. 2018 Sep 28;46(17):9252. doi: 10.1093/nar/gky674. Nucleic Acids Res. 2018. PMID: 30053067 Free PMC article. No abstract available.
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review.
Lo CKL, Komorowski AS, Hall CW, Sandstrom TS, Alamer AAM, Mourad O, Li XX, Al Ohaly R, Benoit MÈ, Duncan DB, Fuller CA, Shaw S, Suresh M, Smaill F, Kapoor AK, Smieja M, Mertz D, Bai AD; McMaster Infectious Diseases Fellow Research Group. Lo CKL, et al. Among authors: fuller ca. Clin Infect Dis. 2023 Oct 5;77(7):1023-1031. doi: 10.1093/cid/ciad308. Clin Infect Dis. 2023. PMID: 37243351
Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma.
Fox CP, Phillips EH, Smith J, Linton K, Gallop-Evans E, Hemmaway C, Auer DP, Fuller C, Davies AJ, McKay P, Cwynarski K; British Society for Haematology. Fox CP, et al. Among authors: fuller c. Br J Haematol. 2019 Feb;184(3):348-363. doi: 10.1111/bjh.15661. Epub 2018 Nov 23. Br J Haematol. 2019. PMID: 30467845 Free article. No abstract available.
15 results